HIGHER: Aravive (ARAV), up 220% after announcing new data from the ongoing Phase 1b portion of the Phase 1b/2 clinical trial of AVB-500 in platinum-resistant recurrent ovarian cancer patients. The data from the first 31 patients treated at the 10mg/kg dose are maturing and affirm earlier findings on the relationship between AVB-500 levels and anti-tumor response, the company said... Endo (ENDP), up 4% after announcing that the FDA has accepted for review the original biologics license application for collagenase clostridium histolyticum. UP AFTER EARNINGS: Target (TGT), up 10%... Lowe's (LOW), up 5%... Qiwi (QIWI), up 3%. DOWN AFTER EARNINGS: Urban Outfitters (URBN), down 15%... PagSeguro Digital (PAGS), down 5%... Pinduoduo (PDD), down 22%... Avaya (AVYA), down 3%. LOWER: Quidian (QD), down 3% after Macquarie analyst Dexter Hsu downgraded shares to Underperform from Neutral with a price target of $4, down from $7. The analyst sees increasing risks from asset quality and regulation.
